The percentage of U.S. adults with obesity did not significantly rise from 2013 to 2023, though a small uptick in the rate of ...
As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...
Allowing such medications as options could lead to significant savings from improved health, writes Kelley Koch.
Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...
Experts reveal how to navigate psychological barriers to achieve healthier eating and exercise habits for weight loss.
An obesity medicine physician writes that weight-loss drugs such as Ozempic have been getting a bad rap, almost as if those ...
How can we best treat infectious diseases in people with obesity? Hospital pharmacist and Ph.D. researcher Koen van Rhee ...
Scientists mapped fat tissue differences in obese individuals, uncovering cell changes linked to metabolic disease risk and ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
Kennedy has expressed support for some fields, but has also declared he’d like a ‘break’ in infectious-disease research.
Congressional District faces significant health challenges, with obesity at 40.4%, diabetes at 12.3% and high blood pressure at 37%. Life expectancy is 75.9 years, below the U.S. average of 78.7 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results